As the national voice for Canada’s biotech industry, BIOTECanada has championed policies that drive innovation, investment, and the growth of Canadian companies. With new federal leadership in place, we remain committed to advancing strong regulatory frameworks and investment policies that position Canada as a global biotech leader.
With the right regulatory leadership and competitive investment policies in place, Canada has an opportunity to strengthen its life sciences sector. Recent years have seen the sector attract more than $25 billion in investment, tangible proof of its growing strength and potential. At the same time, other leading economic jurisdictions in the world are investing heavily into their own domestic life sciences sectors, recognizing the vital role biotechnology innovation is playing in the global economy, health security, and sovereignty. With the right approach, we can develop and commercialize breakthrough innovations that continue to drive domestic economic growth and improve global health.
We look forward to working with the new cabinet to ensure biotechnology innovation and development remains a key driver of Canada’s economic growth and global competitiveness.